Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (61)	12/8/1998 5:54:00 PM
From: Steven Messina,L.M.T.	Read Replies (1) \| Respond to of 75

FT states that decision is expected this morning. I assume that's London/Swiss time. What time is it over there now? May we wake up to the news first thing in the morning? Steve

To: Henry Niman who wrote (61)	12/8/1998 6:11:00 PM
From: Steven Messina,L.M.T.	Read Replies (1) \| Respond to of 75

From the Fool: Dec 08, 1998 (6:02 PM ET) - The Motley Fool Evening News Swedish drug maker Astra AB (NYSE:A - news) jumped $3 5/8 to $21 7/8 and British counterpart Zeneca Group PLC (NYSE:ZEN - news) rose $4 1/4 to $45 before trading in both stocks was halted at around 1:30 p.m. Eastern time. Shortly thereafter, the companies announced that they are in "advanced" discussions that could lead to a possible merger. If a deal can be worked out, the combined company will sport Zeneca's stable of cancer treatments, led by Zestril, and Astra's well-established Losic ulcer franchise, which is marketed as Prilosic in the U.S. and accounted for about 55% of Astra's Q3 sales. Rumors that Astra was seeking a merger with Zeneca, Germany's Bayer AG, or even U.S. drug heavyweight Schering-Plough (NYSE:SGP - news) have been in the markets almost all year. With 1999 fast approaching, those rumors appear to be on the cusp of becoming reality.